Back to search

Article

PCSK9 inhibitors ameliorate arterial stiffness in ACS patients: evidences from mendelian randomization, cohort studies and basic experiments

2024-03-08

Abstract excerpt

<h4>Background: </h4> Current evidences suggest that Proprotein Convertase Subtilisin/kexin Type 9 inhibitors (PCSK9i) exhibit a protective influence on acute coronary syndrome (ACS). Nevertheless, further investigation is required to comprehend the impact and mechanisms of these pharmaceutical agents on inflammatory factors and arterial stiffness (AS) in patients with ACS. Consequently, the objective of this stud...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
92614f09-c4b8-5922-8d46-9cbba8bc71af
DOI
10.21203/rs.3.rs-4008037/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PCSK9 inhibitors ameliorate arterial stiffness in ACS patients: evidences from mendelian randomization, cohort studies and basic experimentsDOI 10.21203/rs.3.rs-4008037/v1
Impact of PCSK9 inhibitors on bone disease: A comprehensive drug-target Mendelian randomization studySemantic proximity
Lipid-lowering and antihypertensive drugs on aortic disease risk: insights from Mendelian randomization analysis and real-world pharmacovigilance data.Semantic proximity
Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes.Semantic proximity
PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis.Semantic proximity
Genetic inhibition of <i>PCSK9</i> , atherogenic lipoprotein concentrations, and calcific aortic valve stenosisSemantic proximity
Unveiling novel drug targets for atherosclerosis: A Mendelian randomization analysis.Semantic proximity
Proprotein Convertase Subtilisin/Kexin Type 9 in the Inflammation-Related Dyslipidemia of Patients with Axial Spondyloarthritis is Related to Disease Activity.Semantic proximity
Effect of PCSK9 Inhibitors on Regulators of Lipoprotein Homeostasis, Inflammation and CoagulationSemantic proximity
PCSK9 inhibition in myeloid cells enhances cardioprotection beyond its LDL cholesterol-lowering effectsSemantic proximity
Exploring PCSK9 Genetic Impact on Lipoprotein(a) via Dual Approaches: Association and Mendelian Randomization.Semantic proximity
The causal association between lipid-lowering strategies and risk of intracranial aneurysms: A drug-target Mendelian randomization study.Semantic proximity
Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall.Semantic proximity
Select a neighboring publication to make it the new centre.